SPARC: Suicide Prevention Among Recipients of Care

Sponsor
St. Luke's Health System, Boise, Idaho (Other)
Overall Status
Recruiting
CT.gov ID
NCT04893447
Collaborator
Patient-Centered Outcomes Research Institute (Other), Idaho Suicide Prevention Hotline (Jannus, Inc.) (Other), University of Washington (Other), Columbia University (Other), University of Pennsylvania (Other)
1,382
1
2
29.8
46.3

Study Details

Study Description

Brief Summary

Randomized controlled trial to determine the best brief suicide prevention intervention for adults and adolescents who screen positive for suicidal ideation or behavior in emergency departments or primary care clinics.

Aim 1: Compare the effectiveness of two brief suicide prevention interventions (safety planning intervention plus structured phone-based follow-up from a suicide prevention hotline (SPI+), versus safety planning intervention plus caring contacts (CC)) to (a) reduce suicidal ideation and behavior, (b) reduce loneliness, (c) reduce return to care for suicidality, and (d) increase uptake of outpatient mental healthcare services over 12 months among adult and adolescent patients screening positive for suicide in emergency departments (EDs) and primary care clinics.

Aim 2: Assess the acceptability of connection and support planning and the safety planning intervention, with or without follow-up among providers and clinical staff in EDs and primary care clinics.

Aim 3: Assess the acceptability of SPI+ and SP+CC among adult and adolescent patients.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
1382 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Individual-level randomization to one of two treatment armsIndividual-level randomization to one of two treatment arms
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Prevention
Official Title:
Comparing the Effectiveness of Safety Planning Plus Follow-Up From a Suicide Prevention Hotline (SPI+) vs Safety Planning Plus Caring Contacts (SP+CC) Among Adults and Adolescents at Risk for Suicide in Primary Care or Emergency Departments
Actual Study Start Date :
May 20, 2021
Anticipated Primary Completion Date :
Nov 14, 2023
Anticipated Study Completion Date :
Nov 14, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: SPI+: Safety Planning Intervention plus structured phone-based follow-up

The Safety Planning Intervention (SPI+) includes safety planning (moderate or high risk for suicide) or connection & support planning (low risk for suicide) at the clinic or ED, plus a structured telephone-based intervention from a suicide prevention hotline

Behavioral: SPI+
Suicide prevention hotline follow-up specialists will call participants to (1) conduct a brief suicide risk assessment; (2) review and discuss the participant's connection and support plan or safety plan; and (3) provide referrals to social services or other support with treatment engagement, if indicated. Participants will receive at least one and optional additional phone calls, generally delivered according to the following schedule: days 3, 7, 14, 30, 60, 90. Modifications may be made to the schedule due to weekends, holidays, or participant availability, and additional calls may be scheduled as desired by the participant. The follow-up will stop once the participant is successfully engaged in outpatient treatment or does not desire further follow-up support.
Other Names:
  • phone-based follow-up, brief contact intervention
  • Experimental: Caring Contacts: Safety Planning Intervention plus Caring Contacts (SP+CC)

    SP+CC will include safety planning (moderate or high risk for suicide) or connection & support planning (low risk for suicide) at the clinic or ED, plus caring text messages or emails from a suicide prevention hotline.

    Behavioral: SP+CC (Caring Contacts)
    SP+CC follow-up includes one phone conversation with a suicide prevention hotline follow-up specialist and a series of personalized caring messages sent over the course of 12 months via text or email (based on participant preference). Caring contacts will generally be sent according to the following schedule: 3 in the first week, 6 weekly, 6 bi-weekly, 4 monthly; 2 bi-monthly, and one each for the participant's birthday, Thanksgiving, Christmas, and New Year's (total of 25 over 12 months). Slight variation in the schedule is allowed. There is no expectation that participants respond to the text messages; if they do, follow-up specialists reply to any incoming texts. Replies are individually-tailored and caring.
    Other Names:
  • Brief contact intervention, text-based follow-up, email follow-up
  • Outcome Measures

    Primary Outcome Measures

    1. Suicidal Ideation & Behavior; measured using the Columbia Suicide Severity Rating Scale (C-SSRS) since-last-contact screener (self-assessment) [6 months]

      6-item questionnaire with yes/no response options. Scores range from 0 (no risk) to 6 (high risk)

    Secondary Outcome Measures

    1. Loneliness; measured using the NIH Toolbox Emotion Batteries Loneliness Scale [6 months]

      5-item questionnaire with Likert scale response options (1=never, 5=always). Scores range from 5 (no loneliness) to 25 (high levels of loneliness).

    2. Loneliness; measured using the NIH Toolbox Emotion Batteries Loneliness Scale [12 months]

      5-item questionnaire with Likert scale response options (1=never, 5=always). Scores range from 5 (no loneliness) to 25 (high levels of loneliness).

    3. Utilization of Emergency Department for Suicidality [6 months]

      Measured through self-report

    4. Utilization of Emergency Department for Suicidality [12 months]

      Measured through self-report

    5. Attendance at Outpatient Behavioral Health Appointments [6 months]

      Measured through self-report

    6. Attendance at Outpatient Behavioral Health Appointments [12 months]

      Measured through self-report

    7. Suicidal Ideation & Behavior; measured using the Columbia Suicide Severity Rating Scale (C-SSRS) since-last-contact screener (self-assessment) [12 months]

      6-item questionnaire with yes/no response options. Scores range from 0 (no risk) to 6 (high risk)

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    12 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Patient at St. Luke's Health System Emergency Department or Primary Care Clinic

    • 12-17 years old (adolescents) or 18+ years old (adults)

    • Screened positive for suicide risk on C-SSRS (any response of "yes") during current visit, or current visit is related to a suicide attempt

    • Completed, Revised, or Reviewed Safety Plan or Connection & Support Plan as part of current visit

    • Access to a phone for the duration of the study with the ability to receive calls

    • The ability to send and receive email messages (required) and text messages (optional)

    • English or Spanish speaking and reading

    Exclusion Criteria:
    • Unable or unwilling to provide informed consent to participate

    • Inappropriate for study participation based on the clinical judgment of provider

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 St. Luke's Health System Boise Idaho United States 83712

    Sponsors and Collaborators

    • St. Luke's Health System, Boise, Idaho
    • Patient-Centered Outcomes Research Institute
    • Idaho Suicide Prevention Hotline (Jannus, Inc.)
    • University of Washington
    • Columbia University
    • University of Pennsylvania

    Investigators

    • Principal Investigator: Anna K Radin, DrPH, MPH, St. Luke's Health System

    Study Documents (Full-Text)

    More Information

    Publications

    None provided.
    Responsible Party:
    Anna Radin, Applied Research Scientist, St. Luke's Health System, Boise, Idaho
    ClinicalTrials.gov Identifier:
    NCT04893447
    Other Study ID Numbers:
    • 2019-0026
    First Posted:
    May 19, 2021
    Last Update Posted:
    Sep 28, 2021
    Last Verified:
    Sep 1, 2021
    Individual Participant Data (IPD) Sharing Statement:
    Yes
    Plan to Share IPD:
    Yes
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Anna Radin, Applied Research Scientist, St. Luke's Health System, Boise, Idaho
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Sep 28, 2021